127 related articles for article (PubMed ID: 7708263)
1. Clinical significance of exit-site infections due to Xanthomonas in CAPD patients: a comparison with Pseudomonas infection.
Dapena F; Selgas R; Garcia-Perea A; Del Peso G; Bajo MA; Fernandez Reyes MJ; Jimenez C; Sánchez C; Muñoz I; De Alvaro F
Nephrol Dial Transplant; 1994; 9(12):1774-7. PubMed ID: 7708263
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
3. Treatment of mycobacterial exit-site infections in patients on continuous ambulatory peritoneal dialysis.
Kleinpeter MA; Krane NK
Adv Perit Dial; 2001; 17():172-5. PubMed ID: 11510269
[TBL] [Abstract][Full Text] [Related]
4. Outcome of Pseudomonas aeruginosa exit-site and tunnel infections: a single center's experience.
Szabo T; Siccion Z; Izatt S; Vas SI; Bargman J; Oreopoulos DG
Adv Perit Dial; 1999; 15():209-12. PubMed ID: 10682104
[TBL] [Abstract][Full Text] [Related]
5. Catheter revision for the treatment of intractable exit site infection/tunnel infection in peritoneal dialysis patients: a single centre experience.
Cho KH; DO JY; Park JW; Yoon KW
Nephrology (Carlton); 2012 Nov; 17(8):760-6. PubMed ID: 22804821
[TBL] [Abstract][Full Text] [Related]
6. Frequency of various types of peritoneal catheter infections and therapeutic outcome of treatment.
Gucek A; Benedik M; Zakelj B; Stanisavljevic D; Lindic J; Hergouth V; Bren AF
Adv Perit Dial; 1995; 11():149-51. PubMed ID: 8534690
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis.
Krothapalli R; Duffy WB; Lacke C; Payne W; Patel H; Perez V; Senekjian HO
Arch Intern Med; 1982 Oct; 142(10):1862-3. PubMed ID: 6812523
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous cuff removal in persistent exit-site/tunnel infections in peritoneal dialysis.
Suh H; Wadhwa NK; Cabralda T
Adv Perit Dial; 1995; 11():157-9. PubMed ID: 8534693
[TBL] [Abstract][Full Text] [Related]
9. Treatment and prevention of relapses of CAPD Pseudomonas peritonitis.
Pasadakis P; Thodis E; Eftimimiadou A; Panagoutsos S; Papazoglou D; Kaliengidou M; Kartali S; Vargemezis V
Adv Perit Dial; 1993; 9():206-10. PubMed ID: 8105925
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
[TBL] [Abstract][Full Text] [Related]
11. Exit-site/tunnel infection and catheter outcome in peritoneal dialysis patients.
Wadhwa NK; Cabralda T; Suh H; Kvilekval K; Mason R
Adv Perit Dial; 1992; 8():325-7. PubMed ID: 1361816
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous removal and reinsertion of Tenckhoff catheters for the treatment of refractory exit-site infection.
Lui SL; Li FK; Lo CY; Lo WK
Adv Perit Dial; 2000; 16():195-7. PubMed ID: 11045292
[TBL] [Abstract][Full Text] [Related]
13. Persistent exit-site/tunnel infection and subcutaneous cuff removal in PD patients.
Suh H; Wadhwa NK; Cabralda T; Bonanno J; Wasiluk A; Sorrento J
Adv Perit Dial; 1997; 13():233-6. PubMed ID: 9360689
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas peritonitis in CAPD patients: characteristics and outcome of treatment.
Chan MK; Chan PC; Cheng IP; Chan CY; Ng WS
Nephrol Dial Transplant; 1989; 4(9):814-7. PubMed ID: 2516614
[TBL] [Abstract][Full Text] [Related]
15. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.
Cavdar C; Saglam F; Sifil A; Celik A; Atay T; Gungor O; Ozder A; Gulay Z; Camsari T
Ren Fail; 2008; 30(4):417-22. PubMed ID: 18569916
[TBL] [Abstract][Full Text] [Related]
16. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.
Zeybel M; Ozder A; Sanlidag C; Yildiz S; Cavdar C; Ersoy R; Celik A; Camsari T
Adv Perit Dial; 2003; 19():198-201. PubMed ID: 14763062
[TBL] [Abstract][Full Text] [Related]
17. Recurrent and relapsing peritonitis: causative organisms and response to treatment.
Szeto CC; Kwan BC; Chow KM; Law MC; Pang WF; Chung KY; Leung CB; Li PK
Am J Kidney Dis; 2009 Oct; 54(4):702-10. PubMed ID: 19577352
[TBL] [Abstract][Full Text] [Related]
18. Exit site infections: systematic microbiologic and quality control are needed.
Freitas C; Rodrigues A; Carvalho MJ; Cabrita A
Adv Perit Dial; 2009; 25():26-31. PubMed ID: 19886313
[TBL] [Abstract][Full Text] [Related]
19. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
Mahaldar A; Weisz M; Kathuria P
Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
[TBL] [Abstract][Full Text] [Related]
20. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
Sesso R; Parisio K; Dalboni A; Rabelo T; Barbosa D; Cendoroglo M; Pignatari A; Draibe S; Ajzen H
Clin Nephrol; 1994 Jun; 41(6):370-6. PubMed ID: 8076441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]